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SHORT COMMUNICATION
NET formation can occur independently of RIPK3
and MLKL signaling
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The importance of neutrophil extracellular traps (NETs) in innate immunity is well estab-
lished but the molecular mechanisms responsible for their formation are still a matter of
scientific dispute. Here, we aim to characterize a possible role of the receptor-interacting
protein kinase 3 (RIPK3) and themixed lineage kinase domain-like (MLKL) signaling path-
way, which are known to cause necroptosis, in NET formation. Using genetic and phar-
macological approaches, we investigated whether this programmed form of necrosis is a
prerequisite for NET formation. NETs have been defined as extracellular DNA scaffolds
associated with the neutrophil granule protein elastase that are capable of killing bac-
teria. Neither Ripk3-deficient mouse neutrophils nor human neutrophils in which MLKL
had been pharmacologically inactivated, exhibited abnormalities in NET formation upon
physiological activation or exposure to low concentrations of PMA. These data indicate
that NET formation occurs independently of both RIPK3 and MLKL signaling.
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Introduction
Extracellular DNA traps are a part of the innate immune response
and are seen with many infectious, allergic and autoimmune dis-
eases. They can be generated by several different leukocytes,
including neutrophils, eosinophils, basophils and monocytes, as
well as mast cells [1], whereby the neutrophil extracellular traps
(NETs) have been most frequently studied. Extracellular DNA
traps can bind and kill bacteria [2] and fungi [3] in the extra-
cellular space, but may also contribute to immunopathology [2]
or even cause autoimmunity [4, 5]. While most investigators agree
that NETs contribute significantly to innate immunity, the molec-
Correspondence: Prof. Shida Yousefi
e-mail: shida.yousefi@pki.unibe.ch
ular mechanisms responsible for their formation remain unclear
and in dispute. Our focus is a simple question: Does the neutrophil
need to die in order to provide the extracellular DNA scaffold char-
acteristic for NETs or not?
Necroptosis is a newly discovered regulated cell death path-
way that requires the functions of receptor-interacting protein
kinase 3 (RIPK3) and mixed lineage kinase domain-like (MLKL)
protein [6–9]. Genetic rescue studies using RIPK3 and MLKL
knockout mice suggested that necroptosis triggers inflammation
[6–9]. Interestingly, recent reports also indicate that RIPK3 may
contribute to production of pro-inflammatory cytokines indepen-
dently of its necroptotic activity [10, 11].
The type of cell death postulated as being required for NET
formation has been called “NETosis” [12–14]. Since it has been
suggested that a neutrophil nonapoptotic type of death is required
C© 2015 The Authors. European Journal of Immunology published by WILEY-VCH Verlag GmbH & Co.
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for NET formation in inflammatory processes [2, 12–14], it
seemed possible that the RIPK3-MLKL signaling pathway might
regulate this process. The aim of this study was to investi-
gate whether NETosis is actually necroptosis and whether RIPK3
contributes to NET formation. Using genetically deficient mice and
pharmacological approaches, we now report that NET formation
is a RIPK3-MLKL-independent process.
Results and discussion
Ripk3-deficient neutrophils are able to form functional
NETs
To investigate whether NETosis is actually necroptosis, we stimu-
lated Ripk3-deficient GM-CSF-primed mouse neutrophils with C5a
or LPS, or alternatively, in the absence of priming, with E. coli or
phorbol-12-myristate-13-acetate (PMA), all known triggers of NET
formation. Ripk3-deficient neutrophils (Fig. 1A) were able to form
NETs just as well as neutrophils from wild-type mice (Fig. 1B and
Supporting Information Fig. 1A) and showed no increased spon-
taneous cell death (Supporting Information Fig. 1B). However,
as expected, Ripk3-deficient neutrophils were less susceptible
to undergoing necroptosis as compared to wild-type neutrophils
(Supporting Information Fig. 1B). In addition, the stimuli used
to trigger NET formation did not induce cell death within a time
period of 1 h (Supporting Information Fig. 1C and Movie 1). We
established the formation of NETs by demonstrating the presence
of extracellular DNA fibers associated with elastase (Fig. 1C).
To quantify the dsDNA released by activated neutrophils, we
also collected the culture supernatants and measured the amount
of released dsDNA using PicoGreen fluorescent dye [15]. We
observed no differences in dsDNA release between Ripk3-deficient
and wild-type mouse neutrophils, but, as expected, there were sta-
tistically significant differences in dsDNA release between control
and activated neutrophils derived from both wild-type and RIPK3-
deficient mouse neutrophils (Fig. 1D). Moreover, Ripk3-deficient
neutrophils were able to generate the same amounts of reactive
oxygen species (ROS), measured both by fluorescent and lumi-
nescent methods (Fig. 1E and F), which are known to be required
for NET formation [16]. In addition, Ripk3-deficient neutrophils
exhibited the same extracellular antibacterial killing activity as
wild-type neutrophils (Fig. 1G). Taken together, these data clearly
demonstrate that NET formation by mouse neutrophils is indepen-
dent of RIPK3.
Pharmacological inhibition of MLKL does not prevent
functional NET formation by human neutrophils
Since mouse and human neutrophils may differ in some func-
tional responses, we also performed experiments in the human
system, using a pharmacological approach. To trigger NET for-
mation, we stimulated human neutrophils in the same way as
mouse neutrophils, including E. coli (Fig. 2A). Again, no effect on
cell viability upon NET formation was observed in human neu-
trophils upon NET formation (Supporting Information Fig. 2).
The association between extracellular DNA fibers and elastase was
considered as defining for NET formation (Fig. 2A, right panels).
Quantification of dsDNA release was also verified by PicoGreen
fluorescent dye (Fig. 2B). Pharmacological inhibition of MLKL by
necrosulfonamide (NSA) had no effect on NET formation (Fig. 2A
and B), ROS production (Fig. 2C) or extracellular antibacterial
killing activity (Fig. 2D). In contrast, NSA completely prevented
TNF-α/IAP-antagonist, Smac mimetic AT-406-mediated death in
caspase-8-deficient Jurkat cells, indicating that the compound was
functionally active and able to block necroptosis (Fig. 2E).
Taken together, our data clearly show that NET formation by
mouse and human neutrophils can occur independently of both
RIPK3 and MLKL signaling, and hence independently of necropto-
sis [6–9]. In fact, this study confirms previous work demonstrating
that NET formation does not require cell death to occur at all [16].
The idea of a “suicidal NETosis” [17] and the general concept of
cell death as a requirement for NET formation both need to be
reconsidered.
Materials and methods
Antibodies and reagents
Human GM-CSF was purchased from Novartis Pharma GmbH
(Nu¨rnberg, Germany). German glass coverslips (#1 thickness,
12 mm diameter) were purchased from Karl Hecht GmbH & Co.
KG “Assistent”, Sondheim/Rho¨n, Germany. Black, glass-bottom
96-well and white 96-well plates were purchased from Greiner
Bio-One GmbH (Frickenhausen, Germany). Human and mouse
C5a were purchased from Hycult Biotech (Uden, The Nether-
lands). Lipopolysaccharide (LPS, 055:B5), dihydrorhodamine-
123 (DHR123), Saponin, LB medium and LB Agar were
from Sigma-Aldrich (Buchs, Switzerland). Necrosulfonamide
(NSA), Phorbol 12-myristate 13-acetate (http://en.wikipedia.org/
wiki/Phorbol_12-myristate_13-acetate PMA), and mouse anti-
GAPDH monoclonal antibody (clone 6C5) were from Merck KGaA
(distributed by Millipore, Schaffhausen, Switzerland). DNase I
was purchased fromWorthington Biochemical Corporation (Lake-
wood, NJ, USA). Goat anti-mouse neutrophil elastase polyclonal
antibody (M-18) was from Santa Cruz Biotechnology (distributed
by LabForce AG, Nunningen, Switzerland) and mouse anti-
human neutrophil elastasemonoclonal antibody (clone NP57)was
from Dako (Baar, Switzerland). Quant-iTTMPicoGreen
R©
dsDNA
Assay Kit, propidium iodide (PI), Hanks balanced salt solution
(HBSS), RPMI-1640/GlutaMAX medium, penicillin/streptomycin
as well as Alexa Fluor R© 488-conjugated anti-mouse and anti-
goat secondary antibodies were obtained from ThermoFisher sci-
entific (distributed by LuBioScience GmbH, Lucerne, Switzer-
land). Human TNF-α and mouse GM-CSF were purchased from
R&D Systems (Abingdon, UK) and z-VAD-FMK (zVAD) from BD
Biosciences (Erembodegem, Belgium). Q-VD was ordered from
SM Biochemicals LLC (Anaheim, CA, USA), and mouse TNF-
α was purchased from Enzo Life Sciences (ELS) AG (Lausen,
C© 2015 The Authors. European Journal of Immunology published by
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Figure 1. The formation of mouse NETs is independent of RIPK3. Mature mouse neutrophils were isolated from bone marrow of wild-type and
Ripk3-deficient mice. (A) Immunoblotting. Bone marrow cells from wild-type and Ripk3-deficient mice were analyzed for RIPK3 protein expression.
Three mice per genotype are shown. (B) Quantification of NET-forming neutrophils by confocal microscopy. NET formation following short-term
stimulation (total 45 min) of mouse neutrophils with the indicated triggers. The number of NET-forming neutrophils was determined by counting
the DNA-releasing cells in ten high power fields (Supporting Information Fig. 1A and Supporting Information Movie 1). No statistical differences
were observed between wild-type and Ripk3-deficient cells (n = 3). (C) Representative microscopy. Co-localization (arrows) of elastase (green) with
released DNA (PI, red) assessed by confocal microscopy. Bars, 10 μM. (D) Quantification of dsDNA in supernatants of activated neutrophils using
PicoGreen fluorescent dye. A significant difference in dsDNA release was detected between control and activated cells, but not between wild-type
and Ripk3-deficient neutrophils (n = 3). (E) Total ROS activity assessed by DHR123 fluorescence and flow cytometry (n = 3). (F) Quantification of H2O2
production upon activation of neutrophils was performed using luminescent ROS-Glo that measures H2O2 levels directly in cell culture. Again,
ROS activity is increased in activated mouse neutrophils, but no statistical differences were observed between wild-type and Ripk3-deficient cells
(n = 3). (G) Bacterial killing by colony formation unit (cfu) assay (n = 3). Mouse neutrophils exert antibacterial activity against E. coli that can be
partially blocked by 100 U/mL DNase I. All data are shown as mean ± SEM of the indicated number of independent experiments. *p < 0.05; **p <
0.01; ***p < 0.001; one-way ANOVA test.
C© 2015 The Authors. European Journal of Immunology published by
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Figure 2. The formation of human NETs occurs independently of MLKL signaling. Human blood neutrophils were isolated from healthy donors
by Ficoll-Hypaque centrifugation. (A) Confocal microscopy. NET formation following short-term stimulation (total 45 min) of human neutrophils
with the indicated triggers in the presence and absence of 5 μM NSA. The number of NET-forming neutrophils was determined by counting the
DNA-releasing cells in ten high power fields (n = 5). Representative original data (right). Co-localization of elastase (green) with released DNA (PI,
red) is indicated by the yellow color. Bars, 10 μM. (B) Quantification of dsDNA in supernatants of activated neutrophils using PicoGreen fluorescent
dye (n = 3). (C) Total ROS production by activated human neutrophils in the presence and absence of 5 μM NSA was measured by flow cytometry.
During cell activation, cells were incubated with 1 μM DHR123 (n = 3). (D) Bacterial killing by colony forming unit (cfu) assay. Human neutrophils
exert antibacterial activity against E. coli that can be partially blocked by 100 U/mL DNase I both in the presence and absence of 5 μM NSA (n = 3).
(E) Viability of Jurkat cells was analyzed by ethidium bromide exclusion assay. In parallel experiments, 5 μM NSA blocked cell death induced by
20 ng/mL TNF-α plus 100 nM Smac mimetic AT-406 (cIAP1/2 selective IAP-antagonist) in caspase-8 deficient and 20 μM zVAD-FMK–treated Jurkat
cells (n = 3), demonstrating that the inhibitor was pharmacologically active. All data are shown as mean ± SEM of the indicated number of
independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001; one-way ANOVA test.
C© 2015 The Authors. European Journal of Immunology published by
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Switzerland). X-VIVOTM 15 medium with no phenol red and no
antibiotics was from Lonza (Verviers, Belgium). Rabbit anti-mouse
RIPK3 polyclonal antibody was from ProSci Inc (Poway, CA, USA).
The monovalent Smac mimetic compound AT-406 was from Sel-
leckchem (Houston, TX, USA) and the ROS-GloTMH2O2 kit was
purchased from Promega AG (Du¨bendorf, Switzerland). The pro-
tease inhibitor cocktail was from Roche Diagnostics (Rotkreuz,
Switzerland). GFP-labeled E.coli M91655 (GFP-E. coli) was a kind
gift of Dr. E. Slack (ETH Zurich, Switzerland).
Neutrophils
Written, informed consent was obtained from all blood donors.
The Ethics Committee of the Canton of Bern approved this study.
Human blood neutrophils were purified from healthy individu-
als by Ficoll-Hypaque centrifugation as previously described [16].
Briefly, peripheral blood mononuclear cells (PBMC) were sepa-
rated by centrifugation on Pancoll Human from PANTM BioTech
(PAN-Biotech GmbH, Aidenbach, Germany). The lower layer con-
sisting mainly of granulocytes and erythrocytes was treated with
erythrocyte lysis solution (155 mM NH4Cl, 10 mM KHCO3 and
0.1 mM EDTA, pH 7.3). The resulting cell populations contained
>95% neutrophils as assessed by staining with the Hematocolor
Set (Merck KGaA) followed by light microscopy analysis. Primary
bone marrow neutrophils were isolated from wild-type and Ripk3-
deficient mice (C57BL/6N) [18], under animal license 119/2012,
by a negative selection technique using an EasySep Mouse Neu-
trophil Enrichment Kit (Stemcell Technologies, Grenoble, France).
Briefly, bone marrow cells were collected by flushing the femur
with 5 mL of isolation medium (PBS plus 2% FCS, no EDTA
added) using a 26-gauge needle and filtering through a sterile
70-μm nylon cell strainer. Bone marrow single-cell suspensions
were then washed with medium and the cells counted with a
haemocytometer using the Tu¨rk’s staining solution (Dr. Grogg
Chemie AG, Stettlen, Switzerland). Primary bone marrow neu-
trophils were then isolated by a negative selection technique using
the EasySep Mouse Neutrophil Enrichment Kit (Stemcell Tech-
nologies, Grenoble, France) and the isolation medium described
above. Neutrophil purity was higher than 93% as assessed by stain-
ing with the Hematocolor Set (Merck KGaA) followed by light
microscopic analysis [19].
Immunoblotting
RIPK3 protein expression was analyzed by immunoblotting. 1–5
× 106 cells were washed with PBS and lysed in modified RIPA
buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 1% Triton-X100,
0.5% Na-deoxycholate, 0.1% SDS, 2 mM EDTA supplemented
with 0.5 mg/mL pepstatin A and complete protease inhibitor
cocktail). Protein concentrations were determined by BCA pro-
tein assay (Thermo Fisher Scientific) and samples denatured
in reducing Laemmle buffer prior to separation by SDS/PAGE
gel electrophoresis. Proteins were blotted on PVDF transfer
membrane (Merck KGaA) and subsequently probed with the
following primary antibodies: Rabbit anti-mouse RIPK3 polyclonal
antibody (1:1000) or mouse anti-GAPDH monoclonal antibody
(1:10 000). Secondary antibodies coupled to horseradish peroxi-
dase were from GE Healthcare Life Sciences (distributed by VWR
International GmbH, Dietikon, Switzerland) and signals detected
by enhanced chemiluminescence (ECL Western blotting substrate,
Thermo Fisher Scientific) and detected on photosensitive film (ECL
Hyperfilm, GE Healthcare Life Sciences).
Confocal laser scanning microscopy
and quantification of NET formation
Human neutrophils were resuspended in X-VIVOTM 15 medium
(2.5 × 106/mL) and were pre-incubated for 30 min in presence
or absence of 5 and 15 μM NSA. One hundred microliters of
cell suspension was primed with 25 ng/mL GM-CSF for 20 min on
untreated glass coverslips which had previously been washed with
acetone, ethanol, ddH2O and baked in an oven. Cells were subse-
quently stimulated with 10−8 M C5a or 0.3 μg/mL LPS. Unprimed
neutrophils were incubated with E. coli (1:3 ratio) or 25 nM PMA
for 15 min. Cells were then fixed with 4% paraformaldehyde for
5 min, subsequently washed three times in PBS (pH 7.4), and
mounted in ProLong Gold mounting medium. For extracellular
DNA detection, cells were stained with 5 μM MitoSOX Red and
1 μg/mL Hoechst 33342.
Neutrophil elastase co-localization with extracellular DNA was
analyzed by indirect immunofluorescence as previously described
[20]. Briefly, cells were fixed with 4% paraformaldehyde and per-
meabilized with 0.05% saponin. Monoclonal mouse antibody to
human neutrophil elastase (1:1000) or polyclonal goat anti-mouse
neutrophil elastase (1:100) served as primary antibodies. Alexa
Fluor R© 488 conjugated secondary antibody was used at 1:400.
In these experiments, cells were stained with 10 μg/mL PI for
extracellular DNA detection.
Slides were examined and images acquired by LSM 700 (Carl
Zeiss Micro Imaging, Jena, Germany) using 63×/1.40 Oil DIC
objective and followed by analysis with IMARIS software as pre-
viously reported [16, 20].
Quantification of released dsDNA in culture
supernatants
Released dsDNA was quantified as previously described [15].
Briefly, 2 × 106 neutrophils in 500 μL of X-VIVOTM 15 medium
were stimulated as described above. At the end of the incubation
time, a low concentration of DNase I (2.5 U/mL;Worthington) was
added for an additional 10 min. Reactions were stopped by addi-
tion of 2.5 mM EDTA, pH 8.0. Cells were centrifuged at 200× g for
5 min. One hundred microliters supernatant were transferred to
black, glass-bottom 96-well plates (Greiner Bio-One GmbH) and
the fluorescent activity of PicoGreen dye bound to dsDNA was
excited at 502 nm and the fluorescence emission intensity was
measured at 523 nm using a spectrofluorimeter (SpectraMax M2,
C© 2015 The Authors. European Journal of Immunology published by
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Molecular Devices, Biberach an der Riß, Germany), according to
the instructions described in the Quant-iTTMPicoGreen
R©
Assay Kit.
Reactive oxygen species measurements
ROS measurements were performed in stimulated mouse and
human neutrophils by two different methods. The fluorescent
detection of ROS activity was done by flow cytometry as previ-
ously described [16, 20]. Briefly, 2 × 106/mL neutrophils were
resuspended in X-VIVOTM 15 medium and 100 μL of cell suspen-
sion was preincubated in the presence and absence of different
inhibitors for 30 min, before priming with 25 ng/mL GM-CSF for
20 min. Cells were then stimulated with 10−8 M C5a or 100 ng/mL
LPS. As a control, we also stimulated neutrophils with 25 nM PMA
for 15 min in the absence of GM-CSF priming. Dihydrorhodamine
123 (DHR 123) was added to the cells at the final concentration
of 1 μM. The reaction was stopped by adding 200 μL of ice-cold
PBS, and ROS activity of the samples was measured immediately
by flow cytometer (BD FACSCalibur) and quantified using FlowJo
software (Ashland, OR, USA).
ROS was also quantified using the ROS-GloTMH2O2 kit
(Promega AG), a luminescent assay that can measure H2O2 lev-
els directly in cell cultures. Briefly, 100 μL of 2.5 × 106/mL neu-
trophils in X-VIVOTM 15mediumwere transferred to white 96-well
plates (Greiner Bio-One GmbH) and 25 μM of H2O2 substrate was
added to the cell suspension. Cells were activated as described
above. ROS-Glo detection solution (D-cysteine, Signal Enhancer
solution and Luciferin detection solution, provided by the kit) was
then added and incubated for 20 min at room temperature, pro-
tected from light. Luminescence activity was detected by GloMax R©
Explorer machine (Promega AG, Du¨bendorf, Switzerland).
Bacterial killing assay
The bacterial killing assay was performed as previously described
[19]. Briefly, a single colony of GFP-E. coli was cultured in Luria
broth base (LB) medium at 37°C, shaking at 220 r.p.m. overnight.
On the next day, the bacterial culture was diluted 1:100 in
LB medium and grown until a mid-logarithmic growth phase
(OD600 = 0.7). Following centrifugation at 1000 × g for 5 min,
bacterial pellets were washed twice with 1× Hank’s Balanced Salt
Solution (HBSS; LuBioScience GmbH) and centrifuged at 100
× g for 5 min to remove any clumped bacteria. Bacteria were
opsonized with 10% mouse sera (heat-inactivated) in 1 × HBSS,
rotating end-over-end (6 r.p.m.) for 20 min at 37°C and used
immediately. Activated neutrophils (1 × 107/mL in RPMI 1640
plus 2% FCS) were mixed with an equal volume of opsonized
bacteria (5 × 107/mL) in the presence and absence of 100 U/mL
DNase I. The co-cultures of cells and bacteria were rotated end-
over-end (6 r.p.m.) for 30 min at 37°C. At the end of the incu-
bation period, an equal volume of ice-cold 1 × HBSS was added
to each tube to stop the reaction, and cells were pelleted by gen-
tle centrifugation (5 min, 100 × g, 4°C) using a swing-out rotor.
Supernatants containing bacteria were collected, diluted 1:300,
plated on agar and grown overnight before counting the colonies.
The tubes containing bacteria alone were treated the same way
and used as controls.
Induction of necroptosis and viability measurements
Necroptosis was induced in 0.5 × 106 cells/mL mouse neutrophils
cultured in complete culture medium (RPMI 1640 plus Gluta-
MAX supplemented with 5% FCS) by adding 1 μM Smac mimetic
AT-406 and 20 μM Q-VD for 30 min, before stimulating with
100 ng/mL mouse TNF-α. Cell viability was determined after 24
and 48 h by ethidium bromide (25 μM) exclusion as assessed by
flow cytometry (BD FACSCalibur).
Functional inhibition ofMLKLwas controlled bymeasuring via-
bility in TNF-α treated caspase-8-deficient Jurkat cells (kind gift of
Dr. T. Brunner, University of Konstanz, Germany). Briefly, caspase-
8-deficient Jurkat cells (1 × 106/mL) were cultured in complete
culture medium with 20 ng/mL recombinant human TNF-α, in
the presence or absence of 100 nM Smac mimetic AT-406, 20 μM
z-VAD, and 5 μM NSA. Cell viability was determined after 24 and
48 h by an ethidium bromide exclusion test as described above.
Statistical analysis
Mean values (± SEM) are provided. To compare groups, one-way
ANOVA was applied. P values < 0.05 were considered statistically
significant.
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